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Abstract
Aims To describe change in self-reported diet and plasma vitamin C, and to examine associations between change in
diet and cardiovascular disease risk factors and modelled 10-year cardiovascular disease risk in the year following
diagnosis of Type 2 diabetes.
Methods Eight hundred and sixty-seven individuals with screen-detected diabetes underwent assessment of
self-reported diet, plasma vitamin C, cardiovascular disease risk factors and modelled cardiovascular disease risk at
baseline and 1 year (n = 736) in the ADDITION-Cambridge trial. Multivariable linear regression was used to quantify
the association between change in diet and cardiovascular disease risk at 1 year, adjusting for change in physical activity
and cardio-protective medication.
Results Participants reported significant reductions in energy, fat and sodium intake, and increases in fruit, vegetable
and fibre intake over 1 year. The reduction in energy was equivalent to an average-sized chocolate bar; the increase in
fruit was equal to one plum per day. There was a small increase in plasma vitamin C levels. Increases in fruit intake and
plasma vitamin C were associated with small reductions in anthropometric and metabolic risk factors. Increased
vegetable intake was associated with an increase in BMI and waist circumference. Reductions in fat, energy and sodium
intake were associated with reduction in HbA1c, waist circumference and total cholesterol/modelled cardiovascular
disease risk, respectively.
Conclusions Improvements in dietary behaviour in this screen-detected population were associated with small
reductions in cardiovascular disease risk, independently of change in cardio-protective medication and physical activity.
Dietary change may have a role to play in the reduction of cardiovascular disease risk following diagnosis of diabetes.
Diabet. Med. 31, 148–155 (2014)
Introduction
Type 2diabetes is a growingpublic health problem, associated
with a substantial burden of morbidity and mortality [1].
Patients with diabetes are two to four times more likely to die
from cardiovascular disease than thosewithout the disease [2].
Lifestyle behaviours, including diet, are strongly associated
with risk of incident diabetes and other cardiovascular disease
risk factors. Dietary modification for weight management and
for controlling blood glucose, blood pressure and blood lipid
levels, is an important first-line treatment option for newly
diagnosed patients. Such individualswill also be given physical
activity advice and may be considered for pharmacotherapy.
Evidence-informed nutritional guidelines for the management
of diabetes from Diabetes UK [3] and the American Diabetes
Association [4] focus on the reduction of total energy intake,
percentage of energy from saturated fat, and sodium intake,
alongside increases in fibre, and fruit and vegetable intake.
Randomized trials of lifestyle interventions including dietary
modification have demonstrated reduced incidence of diabetes
in high-risk individuals [5] and improved cardiovascular
disease risk factors in those with established diabetes [6,7].
Although less well established, research also suggests that
dietary changes in individuals with newly or recently diag-
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nosed diabetes may be valuable [8,9]. However, the lack of
measurement of diet makes it difficult to quantify the contri-
bution that dietary change made to the beneficial effects
observed in these trials.
Population screening for diabetes has been recommended
by several national organizations and the National Health
Service (NHS) includes assessment of diabetes in its Health
Checks programme [10]. Consequently, more individuals
will be found earlier in the disease trajectory, where there is
little current evidence for treatment recommendations. Fur-
thering our understanding of dietary change and potential
cardiovascular disease risk reduction in individuals with
screen-detected Type 2 diabetes should inform provision of
diabetes care and improve targeting of resources.
ADDITION-Cambridge is a primary care-based study of
screening for Type 2 diabetes, followed by a pragmatic
open-label cluster randomized controlled trial comparing
intensive multifactorial treatment with routine care in
patients with screen-detected diabetes. As dietary behaviour
was measured by both self-report and with plasma vitamin C,
this cohort offers the opportunity to quantify the independent
effect of diet on cardiovascular disease risk early in the disease
trajectory. We aimed (1) to describe changes in self-reported
diet and plasma vitamin C over 1 year and (2) to explore
whether change in diet was associated with a reduction in
cardiovascular disease risk factors and modelled cardiovas-
cular disease risk in this screen-detected population.
Patients and methods
The design and rationale for ADDITION-Cambridge have
previously been reported [11]. In brief, 49 general practice
surgeries in the Eastern region of England (26 in the intensive
treatment group and 23 in the routine care group) recruited
patients through a stepwise screening programme. Individ-
uals were eligible to be invited for screening if they were
registered with one of the participating general practices,
were aged 40–69 years, not known to have diabetes and with
a diabetes risk score of > 0.17 (corresponding to the top 25%
of the population distribution [12]). Exclusion criteria
included pregnancy, lactation, and illness with a life expec-
tancy of less than 12 months or a psychiatric disorder that
might invalidate informed consent. In total, 33 539 eligible
participants were invited to take part in the screening
programme [13]. World Health Organization criteria were
used to diagnose diabetes [14]. Patients with newly diag-
nosed Type 2 diabetes in the screening phase were eligible to
participate in the treatment study, unless their general
practitioner indicated that they had contraindications to
proposed study medication. Eight hundred and sixty-seven
individuals agreed to participate and all respondents pro-
vided written informed consent. Ethics approval was granted
by the Eastern Multi-Regional Ethics Committee (reference
02/5/54).
Participants detected with Type 2 diabetes were managed
according to the treatment regimen to which their practice
was allocated: intensive treatment or routine care. In
intensive treatment practices, the intensification of diabetes
management was achieved through the addition of a number
of features to existing diabetes care [11,15]. This included
funding to support increased frequency of contact between
patients and practitioners, dietician referrals, a minimum of
three practice-based meetings incorporating case-based
academic detailing, target setting, audit and feedback. Also
included were treatment algorithms specifying a stepwise
target-led drug treatment regime to reduce hyperglycaemia,
blood pressure, hyperlipidaemia and microalbuminuria. The
intensive treatment programme also included lifestyle advice
concerning diet, physical activity and tobacco consumption,
and provision of theory-based education materials and
glucometers for patients, with training in their use. Routine
care practices followed current UK national guidelines for
diabetes management [16–18].
Measurement and outcomes
Baseline and 1-year health assessments included physiolog-
ical and anthropometric measurements, venesection and the
completion of questionnaires. Anthropometric and clinical
measurements were undertaken by trained staff following
standard operating procedures. These data collection meth-
ods have been described previously [11]. Systolic blood
pressure was calculated as the mean of three measurements
after at least 10 min rest, using an automatic sphygmoma-
nometer (Omron M4; Omron, Milton Keynes, UK). Total
cholesterol and HDL cholesterol were measured by means of
enzymatic techniques (dimension analyser; Dade Behring,
What’s new?
• Dietary modification is an important first-line treatment
option for clinically diagnosed patients.
• Dietary changes in individuals with screen-detected
diabetes may also be valuable. However, the lack of
measurement of diet in previous trialsmakes it difficult to
quantify the contribution that dietary change can make
to cardiovascular risk reduction in this patient group.
• Improvements in self-reported dietary behaviour and
plasma vitamin C over 1 year in our screen-detected
population were associated with small reductions in
cardiovascular disease risk factors and modelled car-
diovascular disease risk, independently of
cardio-protective medication and physical activity.
• Dietary change may have a role to play in the reduction
of cardiovascular disease risk following diagnosis of
diabetes.
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Newark, DE, USA). HbA1c was analysed in venous samples
by ion-exchange high-performance liquid chromatography
on a Tosoh machines (Tosoh Bioscience, Redditch, UK).
Modelled 10-year risk of cardiovascular disease was calcu-
lated using the UK Prospective Diabetes Study (UKPDS)
engine version 3.0 [19]. Participants with complete data for
risk score variables (sex, ethnicity, smoking status, presence
or absence of atrial fibrillation, systolic blood pressure,
HbA1c, total cholesterol, HDL cholesterol) and without a
self-reported history of macrovascular disease were assessed.
Standardized questionnaires were used to collect informa-
tion on socio-demographic characteristics (education,
socio-economic status) and lifestyle habits (smoking status,
alcohol consumption). Data on dietary behaviour was
collected using a validated food frequency questionnaire
[20]. This self-report questionnaire is designed to measure
usual food intake during the past year and asks for the
average intake of specific foods. Data on total energy, fat,
fibre, salt and fruit and vegetable intake were extracted from
the questionnaire. Dietary behaviour was also measured
using plasma vitamin C, a previously validated biomarker
for fruit and vegetable intake, reflecting recent dietary intake
of vitamin C [20]. Levels were established using a Fluoros-
kan Ascent FL fluorometer (Thermo Scientific, Wilmington,
DE, USA). The validated European Prospective Investigation
of Cancer (EPIC)-Norfolk physical activity questionnaire
[21] was used to collect self-report data on total physical
activity.
Statistical analyses
Baseline and follow-up characteristics were summarized
using means and medians. We compared groups between
baseline and follow-up using McNemar’s test for categorical
data, paired t-tests for continuous data and Wilcoxon signed
rank test for non-normally distributed continuous variables.
Diet change was calculated by subtracting baseline from
follow-up values for each of the dietary outcomes
(self-reported fruit, vegetable, energy and fat intake, and
plasma vitamin C). For fruit and vegetable intake, the unit of
measurement was expressed as 80 g/day, which is roughly
equivalent to one portion of fruit or vegetables to allow ease
of interpretation in regression models. Similarly, the unit for
energy was expressed as 100 kcal/day. Multivariable linear
regression models were used to describe the association
between change in diet and cardiovascular disease risk
factors and modelled cardiovascular disease risk at 1 year;
results are reported as unstandardized b-coefficients. The
residuals of all linear regression models were checked to
ensure that they were consistent with a normal distribution.
All models adjusted for baseline dietary behaviour, age, sex,
randomization group, socio-economic status, change in
smoking status, change in self-reported total physical activity
levels, change in alcohol consumption, and change in
medication where applicable. For analyses in which total
cholesterol or HDL cholesterol was the outcome, the model
was adjusted for change in lipid-lowering medication from
baseline to follow-up; similarly, for systolic blood pressure,
models were adjusted for change in anti-hypertensive med-
ication and, for HbA1c, for prescription of glucose-lowering
medication at 1 year. In the analysis of 10-year modelled
cardiovascular risk, participants with a prior cardiovascular
disease event were excluded (n = 86) and models included
adjustment for change in lipid-lowering, anti-hypertensive
and glucose-lowering medication. Where the exposure was
self-reported dietary fat intake (per cent of total energy
intake from dietary fat), total energy intake was included as a
covariate to enable effects on change in cardiovascular
disease risk factors to be estimated per 1% increase in fat
[22]. This nutrient density approach is useful because it
represents dietary public health recommendations, which are
expressed in terms of percentage of energy from fat. Models
were also run separately by trial arm. As results were largely
similar, the data were pooled and results from linear
regression models based on data from the whole cohort are
presented. Type I error was set at 0.05. All data were
analysed using Stata version 11 (StataCorp., College Station,
TX, USA).
Results
Baseline characteristics of ADDITION-Cambridge partici-
pants with complete data at baseline and follow-up
(n = 736) are presented in Table 1. Participants who did
not attend follow-up were more likely to come from a
manual socio-economic class and were more likely to smoke
than those who did attend. Non-attenders also reported
lower levels of fruit intake and vegetable intake compared
with attenders. For all other baseline characteristics, there
were no significant differences between attenders and
non-attenders (data not shown).
The mean (SD) age of participants was 61.1 (7.1) years.
There were 453 (63%) men, 97% were of Caucasian
ethnicity and 43% were in routine or manual occupations.
At baseline, participants reported consuming a median of
three alcohol units/week and 17% were current smokers. A
significant proportion of the cohort were prescribed
lipid-lowering (23%) and anti-hypertensive medication
(55%). On average, the cohort was obese (33.4 kg/m2) with
an adverse cardiovascular risk profile. The mean 10-year
modelled cardiovascular disease risk was 31%. The
self-reported mean daily energy intake was 1943 kcal/day
and combined daily fruit and vegetable intake was 462 g/
day.
Change in cardiovascular disease risk factors, modelled
cardiovascular disease risk and diet (Table 1)
ADDITION-Cambridge participants reduced their waist
circumference and BMI from baseline to follow-up. They
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also reduced their alcohol consumption and a significant
proportion gave up smoking. Reductions were also seen
for total cholesterol, systolic blood pressure, HbA1c and
modelled cardiovascular disease risk, alongside increases in
the prescription of lipid-lowering, anti-hypertensive and
glucose-lowering medication. HDL cholesterol values
increased. No significant changes in physical activity levels
were reported.
Individuals reported reduced energy, fat and sodium intake
at 1 year compared with baseline. There were significant
increases in self-reported fruit, vegetable and fibre intake.
There was a small but significant increase in plasma
vitamin C levels (+ 2.0 lmol/l). Results were unaffected by
excluding the 69 participants who reported regularly con-
suming tablets containing vitamin C.
Association between change in diet, cardiovascular disease
risk factors and modelled cardiovascular disease risk (Table 2)
Increases in self-reported fruit intake were associated with
small reductions in waist circumference, HbA1c and total
cholesterol, while increased vegetable intake was associated
Table 1 Characteristics of ADDITION-Cambridge participants with complete data at baseline and 1-year follow-up (n = 736)
Characteristics Baseline Missing data One-year follow-up Missing data
Socio-demographic
Age, years 61.1 (7.1) 0/736 – –
Caucasian ethnicity, n (%) 712 (96.7) 0/736 – –
Occupation, n (%) 16/736
Managerial and professional 248 (34.4) – –
Intermediate 165 (22.9) – –
Routine and manual 307 (42.6)
Health behaviours
Current smoker, n (%) 125 (17.0) 0/736 108 (14.9)* 12/736
Median (interquartile range) alcohol intake, units/week 3 (0–10) 11/736 3 (0–9)* 19/736
Self-reported total physical activity, metabolic equivalent h/
day
29.4 (9.8) 0/736 29.5 (10.0) 11/736
Prescribed medication
Lipid-lowering medication, n (%) 172 (23.4) 0/736 404 (55.4)* 7/736
Anti-hypertensive medication, n (%) 408 (55.4) 0/736 485 (66.5)* 7/736
Glucose-lowering medication, n (%) 2 (0.3) 0/736 220 (30.2)* 7/736
Clinical variables
BMI, kg/m2 33.4 (5.6) 4/736 32.3 (5.6)* 3/736
Waist circumference, cm
Men 114.2 (12.9) 0/453 111.4 (12.9)* 2/453
Women 107.5 (13.0) 1/283 103.9 (13.0)* 1/283
Systolic blood pressure, mmHg 141.7 (19.9) 2/736 136.3 (18.5)* 4/736
Total cholesterol, mmol/l 5.4 (1.1) 16/736 4.5 (1.0)* 3/736
HDL cholesterol, mmol/l 1.19 (0.33) 16/736 1.22 (0.34)* 3/736
HbA1c, mmol/mol 56 18/736 48 10/736
HbA1c,% 7.3 (1.7) 18/736 6.5 (0.9)* 10/736
Modelled 10-year cardiovascular disease risk,%† 30.9 (14.5) 23/650 25.5 (12.7)* 35/650
Plasma vitamin C, lmol/l 52.7 (22.3) 75/736 54.4 (23.9)* 27/736
Self-reported dietary intake
Energy intake, kcal/day 1943 (684) 4/736 1693 (559)* 17/736
Median (interquartile range) energy intake, kcal/day 1840 (1493–2339) 4/736 1622 (1316–2012)* 17/736
Fruit intake, g/day 252.9 (213.6) 35/736 298.6 (216.9)* 44/736
Median fruit intake, g/day 210.7 (109.1–336.9) 35/736 255.9 (149.7–396.4)* 44/736
Vegetable intake, g/day 211.5 (123.9) 38/736 234.4 (140.7)* 56/736
Median (interquartile range) vegetable intake, g/day 188.1 (127.1–266.2) 38/736 210.0 (145.6–291.2)* 56/736
Fruit and vegetable intake (combined), g/day 461.9 (271.9) 65/736 529.5 (287.8)* 79/736
Median (interquartile range) fruit and vegetable intake
(combined), g/day
407.1 (270.9–586.3) 65/736 483.1 (344.8–658.3)* 79/736
Fat,% of total energy intake 32.2 (6.2) 4/736 30.6 (6.2)* 17/736
Median (interquartile range) fat,% of total energy intake 32.4 (28.1–36.4) 4/736 30.7 (26.3–34.9)* 17/736
Englyst fibre [non-starch polysaccharides (NSP)] intake,
g/day
16.9 (6.7) 4/736 18.3 (7.4)* 17/736
Median (interquartile range) englyst fibre (NSP) intake,
g/day
15.9 (12.2–20.1) 4/736 17.3 (13.4–21.6)* 17/736
Sodium intake, mg/day 2782 (1083) 4/736 2661 (1042)* 14/736
Median (interquartile range) sodium, g/day 2.7 (2.0 to 3.3) 4/736 2.5 (2.0–3.2)* 14/736
All values are means (SD) unless otherwise indicated.
*P < 0.05 from McNemar’s test for categorical variables, paired t-test for normally distributed continuous variables and Wilcoxon signed
rank test for non-normally distributed continuous variables for baseline vs. follow-up (separately in men and women).
†Participants with a prior cardiovascular disease event (n = 86) were excluded.
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with an increase in BMI and waist circumference. A
reduction in fat and energy intake was associated with a
reduction in HbA1c and waist circumference, respectively.
The largest number of associations was seen for plasma
vitamin C, where an increase was associated with a signif-
icant reduction in BMI, waist circumference, HbA1c and
modelled cardiovascular disease risk. A reduction in sodium
was associated with a reduction in total cholesterol and
modelled cardiovascular disease risk. There were no associ-
ations between change in dietary factors and systolic blood
pressure or HDL cholesterol at 1 year. Change in fibre intake
from baseline to 1 year was not associated with any
cardiovascular disease risk factor outcome.
Discussion
We observed improvements in self-reported dietary
behaviour over 12 months in a population of patients newly
diagnosed with diabetes in the East of England.
These changes were associated with small reductions in
cardiovascular disease risk factors and modelled cardiovas-
cular disease risk after allowing for changes in self-reported
cardio-protective medication and physical activity. Our
results suggest that dietary change may have a role to play
in cardiovascular disease risk reduction in individuals with
screen-detected diabetes in the first year following diagnosis.
Reductions in cardiovascular disease risk factors have been
observed in patients with diabetes enrolled in lifestyle
interventions [6–9] and in high-risk individuals enrolled in
diabetes prevention programmes [5]. In the Diabetes Preven-
tion Programme [23], weight loss was the dominant predic-
tor of reduced risk of progression to diabetes. A lower per
cent of dietary calories from fat and increased physical
activity independently predicted weight loss. Similarly,
weight loss predicted reduced progression to diabetes in the
Finnish Diabetes Prevention Study [24]. The predictors of a
reduction in weight were a low intake of total fat and high
dietary fibre intake. More recently, in the Early Activity in
Diabetes (Early ACTID) trial, 593 patients recently diag-
nosed with diabetes were randomized to (1) usual care
(control), (2) an intensive diet intervention (6.5 h of indi-
vidual counselling by a dietician/nurse over 1 year) or (3) an
intensive diet intervention plus a pedometer-based activity
programme [8]. After 12 months, there were significant
improvements in glycaemic control, insulin resistance and
body weight in both intervention groups compared with the
control group; however, the addition of the activity
intervention conferred no extra benefit. One-year results
from the Diabetes Education and Self Management for
Ongoing and Newly Diagnosed (DESMOND) study [9],
undertaken in newly diagnosed Type 2 diabetes, suggested
that a structured education programme, including a focus on
lifestyle factors such as food choices, was associated with
reductions in weight and modelled cardiovascular disease
risk after adjustment for baseline values and cluster effect.Ta
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However, as dietary behaviour was not recorded, the
independent effects of diet on cardiovascular disease risk
factors could not be quantified in the Early ACTID and
DESMOND trials.
Significant increases in self-reported fruit and vegetable
intake over 12 months were mirrored by a small increase in
plasma vitamin C in our cohort. The largest number of
statistically significant associations were seen for associations
between plasma vitamin C and cardiovascular disease risk
factors, rather than for associations with self-reported
dietary intake. This may reflect relative precision of
measurement and confirms findings from other studies. For
example, in the large population-based EPIC-Norfolk
cohort, a much stronger inverse association was observed
between plasma vitamin C and diabetes risk (odds
ratio 0.38, 95% CI 0.28–0.52), than for self-reported fruit
and vegetable intake and diabetes risk (odds ratio 0.78,
95% CI 0.60–1.00) [25]. The importance of dietary change
following diagnosis may have been underestimated in previ-
ous studies limited by self-report measures.
Strengths and limitations
Anthropometric and clinical measurements were under-
taken by trained staff following standard operating proce-
dures. Diet was measured across a number of different
domains (fruit/vegetable, energy, fat, salt and fibre intake),
using a validated food frequency questionnaire. In addition,
the study included measurement of plasma vitamin C,
which is not endogenously produced and therefore provides
a robust measurement of consumption. In order to examine
the independent effects of dietary change on cardiovascular
disease risk, a number of variables were adjusted for,
including change in medication use and change in total
physical activity between baseline and 1 year, which might
have impacted on cardiovascular disease risk at follow-up.
Other intervention studies have not been able to adjust for
these factors [8,9,26–28]. The study is of larger size and
longer duration than many studies in patients with Type 2
diabetes, which are typically limited to less than 1 year.
Nearly half of all practices approached agreed to partici-
pate [13] and, as general practice registers typically cover
99% of all residents living in England, ADDITION-Cam-
bridge participants were drawn from a large popula-
tion-based sample, ensuring generalizability to similar
settings.
Extrapolation of our results to more deprived and ethically
diverse settings may be limited in light of the non-random
recruitment of general practices from a single geographical
region (Eastern England). Some ‘healthy volunteer’ bias may
also be present as non-attenders at 1-year follow up exhibited
more unfavourable lifestyle habits than attenders. We con-
ducted multiple significance tests (> 20) of the association
between change in diet and cardiovascular disease risk
factors, which may have led to an increased risk of type 1
errors. Indeed, we did observe a few associations between
self-reported dietary measures and cardiovascular disease risk
factors, which were not in the expected direction of effect. A
further caution is the use of a self-report food frequency
questionnaire, which may have been subject to more error
and bias than anthropometric and biochemical measures [29].
The food frequency questionnaire used in this study has
previously been shown to overestimate fruit intake and the
food frequency questionnaire and plasma vitamin C had the
weakest correlation compared with other dietary assessment
methods [20]. Further, as most ADDITION-Cambridge
participants were obese, energy intake is likely to have been
under-reported in this cohort. This limitation may have been
attenuated if the degree of bias was consistent at both time
points. Using behaviour change as the exposure of interest
would therefore be reliable. Indeed, the food frequency
questionnaire is comparable with multiple-day diet records
when assessing dietary change [30]. However, the degree of
misclassification may have been different at baseline and
1-year follow-up. Participants would have received dietary
advice following diagnosis and might therefore be more
influenced by social desirability bias at follow-up. Despite
these challenges, we noted significant improvements in
cardiovascular disease risk associated with change in plasma
vitamin C, which removes the reliance on self-report data
[31], suggesting we did observe some real associations. Future
studies might use additional biomarkers for nutritional status
to improve the accuracy of dietary measures.
Conclusion
Significant improvements in dietary behaviour over 1 year
were associated with small reductions in cardiovascular
disease risk factors and modelled cardiovascular disease risk
in a population of patients newly diagnosed with Type 2
diabetes in the East of England. These improvements were
independent of change in cardio-protective medication and
physical activity. This suggests that dietary change may have
a role to play in the reduction of cardiovascular disease risk
following diagnosis of diabetes.
Funding sources
ADDITION-Cambridge was supported by the Wellcome
Trust (grant reference no: G061895), the Medical Research
Council (grant reference no: G0001164), the National
Institute for Health Research (NIHR) Health Technology
Assessment Programme (grant reference no: 08/116/300),
National Health Service R&D support funding (including the
Primary Care Research and Diabetes Research Networks)
and the National Institute for Health Research. SJG receives
support from the Department of Health NIHR Programme
Grant funding scheme (RP-PG-0606-1259). The views
expressed in this publication are those of the authors and
not necessarily those of the NHS, the NIHR or UK
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK 153
Research article DIABETICMedicine
Department of Health. Bio-Rad provided equipment for
HbA1c testing during the screening phase.
Competing interests
None declared.
Acknowledgements
We are grateful to the ADDITION-Cambridge independent
trial steering committee [Nigel Stott (Chair), John Weinman,
Richard Himsworth and Paul Little]. Aside from the authors,
the ADDITION-Cambridge study team has included
Rebecca Abbott, Amanda Adler, Judith Argles, Gisela Baker,
Rebecca Bale, Roslyn Barling, Daniel Barnes, Mark Betts,
Sue Boase, Sandra Bovan, Ryan Butler, Parinya Chamnan,
Sean Dinneen, Pesheya Doubleday, Sue Emms, Mark Evans,
Tom Fanshawe, Francis Finucane, Philippa Gash, Julie
Grant, Wendy Hardeman, Robert Henderson, Susie
Hennings, Muriel Hood, Garry King, Georgina Lewis,
Christine May Hall, Joanna Mitchell, Richard Parker, Nicola
Popplewell, Emanuella De Lucia Rolfe, Lincoln Sargeant,
Megan Smith, Stephen Sutton, Liz White and Fiona Whittle.
We thank the Cambridge University Hospitals NHS Foun-
dation Trust Department of Clinical Biochemistry and the
NIHR Cambridge Biomedical Research Centre, Core Bio-
chemical Assay Laboratory for carrying out the biochemical
assays, and the following groups within the MRC Epidemi-
ology Unit: data management (Adam Dickinson), informa-
tion technology (Iain Morrison), technical (Matt Sims) and
field epidemiology (Paul Roberts, Kim Mwanza and James
Sylvester). ATP was supported by the NIHR Biomedical
Research Centre at Guy’s and St Thomas’ NHS Foundation
Trust and King’s College London.
References
1 IDF. The Diabetes Atlas. 4th edition. Brussels: International
Diabetes Federation, 2009.
2 Laakso M, Lehto S. Epidemiology of macrovascular disease in
diabetes. Diabetes Rev 1997; 5: 294–315.
3 Diabetes UK. Evidence-Based Nutrition Guidelines for the
Prevention and Management of Diabetes. London: Diabetes
UK, 2011. Available at http://www.diabetes.org.uk/Documents/
Reports/Nutritional_guidelines200911.pdf Last accessed 10 July
2012.
4 Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG
et al. American Diabetes Association. Nutrition recommendations
and interventions for diabetes: a position statement of the American
Diabetes Association. Diabetes Care 2008; 31: S61–78.
5 Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu
RT, et al. Pharmacological and lifestyle interventions to prevent
or delay type 2 diabetes in people with impaired glucose
tolerance: systematic review and meta-analysis. Br Med J 2007;
334: 299.
6 Wing RR. Long-term effects of a lifestyle intervention on weight
and cardiovascular risk factors in individuals with type 2 diabetes
mellitus: four-year results of the Look AHEAD trial. Arch Intern
Med 2010; 170: 1566–1575.
7 Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O.
Multifactorial intervention and cardiovascular disease in patients
with type 2 diabetes. N Engl J Med 2003; 348: 383–393.
8 Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters
TJ, Sharp DJ et al. Diet or diet plus physical activity versus usual
care in patients with newly diagnosed type 2 diabetes: the Early
ACTID randomised controlled trial. Lancet 2011; 378: 129–139.
9 DaviesMJ, Heller S, Skinner TC, Campbell MJ, CareyME, Cradock
S et al. Effectiveness of the diabetes education and self management
for ongoing and newly diagnosed (DESMOND) programme for
people with newly diagnosed type 2 diabetes: cluster randomised
controlled trial. Br Med J 2008; 336: 491–495.
10 National Screening Committee. Handbook for Vascular Risk
Assessment, Risk Reduction and Risk Management. University of
Leicester: National Screening Committee, 2008.
11 Echouffo-Tcheugui JB, Simmons RK, Williams KM, Barling RS,
Prevost AT, Kinmonth AL et al. The ADDITION-Cambridge trial
protocol: a cluster—randomised controlled trial of screening for
type 2 diabetes and intensive treatment for screen-detected
patients. BMC Public Health 2009; 9: 136.
12 Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ.
Diabetes risk score: towards earlier detection of type 2 diabetes in
general practice. Diabetes Metab Res Rev 2000; 16: 164–171.
13 Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM,
Prevost AT et al.Who attends a UK diabetes screening programme?
Findings from the ADDITION-Cambridge study. Diabet Med
2010; 27: 995–1003.
14 Alberti KG, Zimmet PZ. Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and
classification of diabetes mellitus provisional report of a WHO
consultation. Diabet Med 1998; 15: 539–553.
15 Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE,
Sandbaek A et al. Effect of early intensive multifactorial therapy on
5-year cardiovascular outcomes in individuals with type 2 diabetes
detected by screening (ADDITION-Europe): a cluster-randomised
trial. Lancet 2011; 378: 156–167.
16 McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A,
Damerell A et al. Clinical Guidelines and Evidence for Type 2
Diabetes: Management of Blood Pressure. Sheffield: University of
Sheffield, 2002.
17 McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A,
Damerell A et al. Clinical Guidelines and Evidence for Type 2
Diabetes: Lipids Management. Sheffield: University of Sheffield,
2002.
18 McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A,
Damerell A et al. Clinical Guidelines and Evidence Review for
Type 2 Diabetes: Management of Blood Glucose. Sheffield:
University of Sheffield, 2001.
19 Coleman R, Stevens R, Holman R, eds. The Oxford Risk
Engine: A Cardiovascular Risk Calculator for Individuals With
or Without Type 2 Diabetes. Chicago: American Diabetic
Association, 2007.
20 Bingham SA, Gill C, Welch A, Cassidy A, Runswick SA, Oakes S
et al. Validation of dietary assessment methods in the UK arm of
EPIC using weighed records, and 24-hour urinary nitrogen and
potassium and serum vitamin C and carotenoids as biomarkers. Int
J Epidemiol 1997; 26: S137–151.
21 Wareham NJ, Jakes RW, Rennie KL, Mitchell J, Hennings S, Day
NE. Validity and repeatability of the EPIC-Norfolk Physical
Activity Questionnaire. Int J Epidemiol 2002; 31: 168–174.
22 Forouhi NG, Sharp SJ, Du H, van der AD, Halkjaer J, Schulze
MB et al. Dietary fat intake and subsequent weight change in
adults: results from the European Prospective Investigation into
Cancer and Nutrition cohorts. Am J Clin Nutr 2009; 90: 1632–
1641.
154
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK
DIABETICMedicine Changes in diet and cardiovascular risk following diagnosis of diabetes  L. A. Savory et al.
23 KnowlerWC, Barrett-Connor E, Fowler SE, HammanRF, Lachin JM,
Walker EA et al. Reduction in the incidence of type 2 diabetes with
lifestyle interventionormetformin.NEngl JMed 2002;346: 393–403.
24 Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H,
Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by
changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med 2001; 344: 1343–1350.
25 Harding AH, Wareham NJ, Bingham SA, Khaw K, Luben R, Welch
A et al. Plasma vitamin C level, fruit and vegetable consumption,
and the risk of new-onset type 2 diabetes mellitus: the European
Prospective Investigation of Cancer—Norfolk prospective study.
Arch Intern Med 2008; 168: 1493–1499.
26 Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni
AG et al. Benefits of modest weight loss in improving
cardiovascular risk factors in overweight and obese individuals
with Type 2 diabetes. Diabetes Care 2011; 34: 1481–1486.
27 Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA,
Delahanty L et al. Effect of weight loss with lifestyle intervention
on risk of diabetes. Diabetes Care 2006; 29: 2102–2107.
28 Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifac-
torial intervention in patients with type 2 diabetes mellitus and
microalbuminuria: the Steno type 2 randomised study. Lancet
1999; 353: 617–622.
29 Schaefer EJ, Augustin JL, Schaefer MM, Rasmussen H, Ordovas
JM, Dallal GE et al. Lack of efficacy of a food-frequency
questionnaire in assessing dietary macronutrient intakes in subjects
consuming diets of known composition. Am J Clin Nutr 2000; 71:
746–751.
30 Kristal AR, Beresford SA, Lazovich D. Assessing change in
diet-intervention research. Am J Clin Nutr 1994; 59: 185S–189S.
31 McKeown NM, Day NE, Welch AA, Runswick SA, Luben RN,
Mulligan AA et al. Use of biological markers to validate self--
reported dietary intake in a random sample of the European
Prospective Investigation into Cancer UK Norfolk cohort. Am J
Clin Nutr 2001; 74: 188–196.
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK 155
Research article DIABETICMedicine
